Intraneuronal APOE in human visual cortical areas reflects the staging, of Alzheimer disease pathology

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 12, 1998, Pages 1190-1201

  Einstein, Gillian ^a,b,e   Patel, Vikas ^a   Bautista, Phillip ^a   Kenna, Michelle ^a   Melone, Leah ^a   Fader, Robyn ^a   Karson, Kris ^a   Mann, Stephanie ^a   Saunders, Ann M ^a,b   Hulette, Christine ^a,b,c   Mash, Deborah ^c   Roses, Allen D ^a,b   Schmechel, Donald E ^a,b,d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Durham Medical Center   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Alzheimer disease; Association cortex; Neuropathology; Pyramidal neurons; Tau

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; NEUROPATHOLOGY; PRIORITY JOURNAL;

EID: 0031743651     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199812000-00011     Document Type: Article

References (33)

1. Braak H and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 1991;82:239-59
2. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 1996;275:528-32
3. Smith AD, Jobst KA. Use of structural imaging to study the progression of Alzheimer's disease. Br Med Bull 1996;52:575-86
4. Plassman BL, Breitner JCS. Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurol 1996;47:317-20
5. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci 1993;90:8098-8102
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-23
7. Strittmatter WJ, Saunders AM, Schmechel DE, et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 1993; 90:1977-81
8. Diedrich J, Minnigan H, Carp RI, Whitaker JN, Race R, Frey W, and Haase AT. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol 1 991;65:4759-68
9. Namba Y, Tomonaga M, Kawasaki H, Otomo E, and Ikeda K. Apolipoprotein E inmmunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-66
10. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, and Selkoe DJ. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 1996;3:16-32
11. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-amyloid-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci 1993;90:9649-53
12. Mufson EJ, Benzing WC, Emerich DE Sladek JR, Morrrison JH and Kordower JH. Apolipoprotein E immunoreactivity in the aged Rhesus monkey cortex: Colocalization with amyloid-containing plaques. Neurobiol Aging 1994;15:621-27
13. Han S-H, Hulette C, Saunders AM, et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 1994; 128:13-26
14. Han S-H, Einstein G, Weisgraber KH. et al. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J Neuropathol Exp Neurol 1994b; 53: 535-44
15. Benzing WC and Mufson EJ. Apolipoprotein E immunoreactivity within neurofibrillary tangles: Relationship to tau and PHF in Alzheimer's disease. Exp Neurol 1995;132:162-71
16. Metzger RE, LaDu MJ, Pan JB, Godfrey S, Getz S, Frail DE, Falduto MT (1996) Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease. J Neuropath Exp Neurol. 55:372-380
17. Braak H , Braak E, and Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993;33:403-8
18. Mirra SS, Heyman A, McKell D, et al. The consortium to establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurol 1991;41:479-86
19. Campbell MJ and Morrison JH. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey cortex. J Comp Neurol 1989;282: 191-205
20. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurol 1993;43:1467-72
21. Horsburgh K and Nicoll JAR. Selective alteration in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat. Alzheimer's Res 1995;1:169-76
22. Skene JHP and Shooter EM. Denervated sheath cells secrete a new protein after nerve injury. Proc Natl Acad Sci USA 1983;80:4169-73
23. Snipes GJ, McGuire CB, Norden JJ, and Freeman JA. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci USA 1986;83:1130-34
24. Ignatius MJ, Gebicke-Harter PJ, Skene JHP, et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 1986;83:1125-29
25. Poirier J. Apolipoprotein E in animal models of CNS injury and in AD. TINS 1994;17:525-30
26. Poirier J, Hess M, May PC, Finch CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991;11:97-106
27. Einstein G, Bautista P, Patel V, et al. Distribution of apoE-immunoreactive neurons in control and AD brains. Soc Neurosci (abstr) 1995;21:1008
28. Morrison JH, Lewis DA, Campbell MJ, Huntley GW, Benson DL, and Bouras C. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's Disease. Brain Res 1987;416:331-36
29. Lewis DA, Campbell MJ, Terry RD and Morrison JH (1987) Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative sudy of visual and auditory cortices. J Neurosci 7:1799-1808
30. Mountjoy CQ, Roth M, Evans NJ, and Evans HM. Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 1983;4:1-11
31. Terry RD, Masliah E, Salmon DP, Butters N, De Teresa R, Hill R, Hansen LA, and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
32. Wilcock GK and Esiri MM. Plaques, tangles and dementia: A quantitative study. J Neurol Sci 1982;56:343-56
33. Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, and Bohl J. Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm 1996;103:455-90